166 related articles for article (PubMed ID: 16420085)
1. Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.
Sernyak MJ; Gulanski B; Rosenheck R
J Clin Psychiatry; 2005 Nov; 66(11):1463-7. PubMed ID: 16420085
[TBL] [Abstract][Full Text] [Related]
2. Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia.
Sernyak MJ; Gulanski B; Leslie DL; Rosenheck R
J Clin Psychiatry; 2003 May; 64(5):605-8. PubMed ID: 12755666
[TBL] [Abstract][Full Text] [Related]
3. Hyperglycemia associated with the use of atypical antipsychotics.
Lindenmayer JP; Nathan AM; Smith RC
J Clin Psychiatry; 2001; 62 Suppl 23():30-8. PubMed ID: 11603883
[TBL] [Abstract][Full Text] [Related]
4. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
[TBL] [Abstract][Full Text] [Related]
5. [Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].
Rubio G; Gómez-de-la-Cámara A; Ledesma F; Burón JA; Rodríguez-Morales A; Martínez-Junquera G;
Med Clin (Barc); 2006 Apr; 126(12):441-4. PubMed ID: 16620729
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications.
Hägg S; Joelsson L; Mjörndal T; Spigset O; Oja G; Dahlqvist R
J Clin Psychiatry; 1998 Jun; 59(6):294-9. PubMed ID: 9671341
[TBL] [Abstract][Full Text] [Related]
7. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
8. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
Leslie DL; Rosenheck RA
Am J Psychiatry; 2004 Sep; 161(9):1709-11. PubMed ID: 15337666
[TBL] [Abstract][Full Text] [Related]
9. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B
J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
[TBL] [Abstract][Full Text] [Related]
10. Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.
Citrome L; Jaffe A; Levine J; Allingham B; Robinson J
Psychiatr Serv; 2004 Sep; 55(9):1006-13. PubMed ID: 15345760
[TBL] [Abstract][Full Text] [Related]
11. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
Ollendorf DA; Joyce AT; Rucker M
MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518
[TBL] [Abstract][Full Text] [Related]
12. Relative risk of glucose elevation during antipsychotic exposure in a Veterans Administration population.
Duncan E; Dunlop BW; Boshoven W; Woolson SL; Hamer RM; Phillips LS
Int Clin Psychopharmacol; 2007 Jan; 22(1):1-11. PubMed ID: 17159454
[TBL] [Abstract][Full Text] [Related]
13. A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus.
Koller EA; Weber J; Doraiswamy PM; Schneider BS
J Clin Psychiatry; 2004 Jun; 65(6):857-63. PubMed ID: 15291665
[TBL] [Abstract][Full Text] [Related]
14. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.
van Winkel R; De Hert M; Wampers M; Van Eyck D; Hanssens L; Scheen A; Peuskens J
J Clin Psychiatry; 2008 Mar; 69(3):472-9. PubMed ID: 18348593
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.
Lamberti JS; Costea GO; Olson D; Crilly JF; Maharaj K; Tu X; Groman A; Dietz MB; Bushey MP; Olivares T; Wiener K
J Clin Psychiatry; 2005 Jul; 66(7):900-6. PubMed ID: 16013906
[TBL] [Abstract][Full Text] [Related]
16. Glucose intolerance with atypical antipsychotics.
Hedenmalm K; Hägg S; Ståhl M; Mortimer O; Spigset O
Drug Saf; 2002; 25(15):1107-16. PubMed ID: 12452735
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycemia and antipsychotic medications.
Haupt DW; Newcomer JW
J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
[TBL] [Abstract][Full Text] [Related]
19. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.
Melkersson KI; Hulting AL; Brismar KE
J Clin Psychiatry; 1999 Nov; 60(11):783-91. PubMed ID: 10584769
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of diabetes mellitus in patients receiving depot neuroleptics or clozapine.
Miller MJ; Molla PM
Arch Psychiatr Nurs; 2005 Feb; 19(1):30-4. PubMed ID: 15765369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
